Insights On Liquid Dose Manufacturing

1. The Rise In Aseptic Manufacturing Solutions With Smaller Footprints 2/19/2025

   Aseptic drug manufacturing is going small. Discover how advanced robotic and automated systems with smaller footprints are changing the landscape and boosting accessibility.

2. 5 Ways Pre-Filled Syringes Contribute To Better Patient Outcomes 5/23/2025

   In our series on pre-filled syringes, we explore five key ways this delivery format is enhancing patient outcomes, not just through the medicine it contains, but through the device design itself.

3. Stability Issues Unique To Liquid Injectables And How To Avoid Them 3/23/2026

   Liquid injectables face stability risks like oxidation, hydrolysis, aggregation, temperature shifts, and packaging effects, requiring early, rigorous formulation and process controls.

4. What Does Annex 1 Mean For Cryovial Filling? 10/6/2025

   New sterile manufacturing rules require major changes to cryovial filling. Ensure compliance by adopting better "first-air" protection, minimizing human contact, and using 100% dose checks.

5. Safe Syringe Solutions For Lipid Nanoparticles 7/1/2026

   Prefilled syringes improve lipid nanoparticle dosing accuracy and administration. Advanced containment solutions with cross-linked coatings preserve stability and accelerate development timelines.

6. Why Lower Endotoxin Levels Matter: Raising The Bar For Patient Safety And Product Quality 5/12/2026

   Strengthen patient safety and regulatory compliance with comprehensive endotoxin control strategies designed to support the evolving demands of injectable and advanced pharmaceutical products.

7. Robust, High-Throughput Automated Solution For Water Endotoxin Testing 4/21/2026

   High-throughput water endotoxin testing doesn’t have to sacrifice consistency. Gain insight into how an automated workflow delivers reliable results, low variability, and strong control recovery.

8. Still Pipette-Filling Cryovials? There's A Better Way 7/7/2025

   Manual cryovial filling in cell therapy is risky, time-consuming, and unsustainable. Learn why automating this crucial step is essential for precision, viability, and scalability.

9. Contamination Control Of Particulate And Shuttle Blow-Fill-Seal Compliance 2/24/2026

   Does shuttle blow-fill-seal truly meet Annex 1’s stricter contamination standards? New particle burden data challenges industry assumptions and reveals what manufacturers need to know.

10. EU GMP-Annex 1: Changes, Challenges, And Ready-To-Use Sterile Packaging 8/27/2024

    Leveraging a pre-sterilized containment solution that meets the requirements of Annex 1 and outsources non-core activities can help prevent contamination and reduce the effort and liability of the CCS.